Feasibility Pilot Exploring Variability in Biomarkers and PROs in AML

Clinical trial NCT04908852 · COMPLETED

Trial details

NCT number: NCT04908852
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Acute Myeloid Leukemia (AML)

Start date: 2021-07-26
Primary completion: 2023-02-23
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.